Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine FP Polack, SJ Thomas, N Kitchin, J Absalon, A Gurtman, S Lockhart, ... New England journal of medicine 383 (27), 2603-2615, 2020 | 15886 | 2020 |
Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates EE Walsh, RW Frenck Jr, AR Falsey, N Kitchin, J Absalon, A Gurtman, ... New England Journal of Medicine 383 (25), 2439-2450, 2020 | 2815 | 2020 |
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses U Sahin, A Muik, E Derhovanessian, I Vogler, LM Kranz, M Vormehr, ... Nature 586 (7830), 594-599, 2020 | 1997 | 2020 |
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults MJ Mulligan, KE Lyke, N Kitchin, J Absalon, A Gurtman, S Lockhart, ... Nature 586 (7830), 589-593, 2020 | 1825 | 2020 |
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months SJ Thomas, ED Moreira Jr, N Kitchin, J Absalon, A Gurtman, S Lockhart, ... New England Journal of Medicine 385 (19), 1761-1773, 2021 | 1508 | 2021 |
Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents RW Frenck Jr, NP Klein, N Kitchin, A Gurtman, J Absalon, S Lockhart, ... New England Journal of Medicine 385 (3), 239-250, 2021 | 1050 | 2021 |
Nonviral delivery of self-amplifying RNA vaccines AJ Geall, A Verma, GR Otten, CA Shaw, A Hekele, K Banerjee, Y Cu, ... Proceedings of the National Academy of Sciences 109 (36), 14604-14609, 2012 | 756 | 2012 |
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans U Sahin, A Muik, I Vogler, E Derhovanessian, LM Kranz, M Vormehr, ... Nature 595 (7868), 572-577, 2021 | 717 | 2021 |
Neutralizing activity of BNT162b2-elicited serum Y Liu, J Liu, H Xia, X Zhang, CR Fontes-Garfias, KA Swanson, H Cai, ... New England Journal of Medicine 384 (15), 1466-1468, 2021 | 670 | 2021 |
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera X Xie, Y Liu, J Liu, X Zhang, J Zou, CR Fontes-Garfias, H Xia, ... Nature medicine 27 (4), 620-621, 2021 | 663 | 2021 |
BNT162b vaccines protect rhesus macaques from SARS-CoV-2 AB Vogel, I Kanevsky, Y Che, KA Swanson, A Muik, M Vormehr, LM Kranz, ... Nature 592 (7853), 283-289, 2021 | 662 | 2021 |
Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age EB Walter, KR Talaat, C Sabharwal, A Gurtman, S Lockhart, GC Paulsen, ... New England Journal of Medicine 386 (1), 35-46, 2022 | 635 | 2022 |
Neutralization of SARS-CoV-2 lineage B. 1.1. 7 pseudovirus by BNT162b2 vaccine–elicited human sera A Muik, AK Wallisch, B Sänger, KA Swanson, J Mühl, W Chen, H Cai, ... Science 371 (6534), 1152-1153, 2021 | 622 | 2021 |
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin JRR Whittle, R Zhang, S Khurana, LR King, J Manischewitz, H Golding, ... Proceedings of the National Academy of Sciences 108 (34), 14216-14221, 2011 | 496 | 2011 |
SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells IC Huang, BJ Bosch, F Li, W Li, KH Lee, S Ghiran, N Vasilieva, ... Journal of Biological Chemistry 281 (6), 3198-3203, 2006 | 451 | 2006 |
Near-atomic resolution using electron cryomicroscopy and single-particle reconstruction X Zhang, E Settembre, C Xu, PR Dormitzer, R Bellamy, SC Harrison, ... Proceedings of the National Academy of Sciences 105 (6), 1867-1872, 2008 | 438 | 2008 |
The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site PR Dormitzer, ZYJ Sun, G Wagner, SC Harrison The EMBO journal, 2002 | 431 | 2002 |
SARS-CoV-2 neutralization with BNT162b2 vaccine dose 3 AR Falsey, RW Frenck Jr, EE Walsh, N Kitchin, J Absalon, A Gurtman, ... New England Journal of Medicine 385 (17), 1627-1629, 2021 | 391 | 2021 |
A cationic nanoemulsion for the delivery of next-generation RNA vaccines LA Brito, M Chan, CA Shaw, A Hekele, T Carsillo, M Schaefer, J Archer, ... Molecular Therapy 22 (12), 2118-2129, 2014 | 365 | 2014 |
Atomic model of an infectious rotavirus particle EC Settembre, JZ Chen, PR Dormitzer, N Grigorieff, SC Harrison The EMBO journal 30 (2), 408-416, 2011 | 360 | 2011 |